Document:

Consulting Agreement by and between the Company and Richard N. Small

 Exhibit 10.04 
 CONSULTING AGREEMENT 
 THIS CONSULTING
AGREEMENT (the “Agreement”) is made and entered into as of this 26th day of July, 2007 (the “Effective Date”) by and between Point
Therapeutics, Inc., a Delaware corporation (the “Company”), and Richard N. Small (the “Consultant”). 
 The
Company wishes to engage the Consultant to provide assistance and expertise for the Company and otherwise to render consulting services upon the terms and conditions contained in this Agreement. 
 NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, accepted and agreed to, the Company and the Consultant hereby agree as follows: 
 1. TERM; SERVICES. 
 1.1 Commencing as of the Effective Date and continuing until terminated by either party hereto upon thirty (30) days written notice
to the other party (the “Term”), the Consultant agrees that he will provide certain consulting services to the Company as from time to time requested by the Company (the “Services”). 
 1.2 The Consultant represents and warrants to the Company that he is under no contractual or other restriction or obligation which is
inconsistent with the execution of this Agreement, or which will materially interfere with the performance of his duties hereunder. 
 2.
CONSULTING FEE. 
 2.1 The Company shall pay the Consultant a consulting fee of Two Hundred Fifty Dollars ($250.00) per
hour to be billed to the Company by the Consultant in quarter hour increments not to exceed an aggregate of Two Thousand Dollars ($2,000.00) per day for services performed during the Term (the “Consulting Fee”). The Consultant shall be
compensated promptly upon the Company’s receipt of a weekly or bi-weekly time sheet in the form attached hereto as Exhibit A. 
 2.2 The Consultant shall be entitled to prompt reimbursement for all pre-approved travel and other out-of-pocket expenses incurred in the performance of his duties hereunder, upon submission and approval of written
statements and bills. 
 2.3 The Consultant agrees that all services hereunder will be rendered by him as an independent
contractor and that this Agreement does not create an employer-employee relationship between the Consultant and the Company. The Consultant shall have no right to receive any employee benefits, including, but not limited to, health and accident
insurance, life insurance, sick leave and/or vacation. 
 3. PROPRIETARY RIGHTS. 
 3.1 Trade Secrets. The Consultant acknowledges and agrees that rendering of Services to the Company will necessarily involve
understanding of and access to “trade secrets” of the Company as hereinafter defined, and “confidential and proprietary information” of the Company. The Consultant agrees during the Term of this Agreement and for a period of five
(5) years thereafter, not to disclose to any unauthorized third party or use for the Consultant’s own benefit any of the trade secret or confidential or proprietary information belonging to the Company. For the purposes hereof, “trade
secret” is information not generally known to the trade, which gives the Company an advantage over its competitors. Trade secrets include without limitation, research being planned and developed, research methods and processes, materials used
in research, inventions, information concerning the filing or pendency of patent applications and the Company’s business and legal plans, finances, competitive position, customers and vendors. 
 3.2 Concepts and Ideas. Those concepts and ideas disclosed by the Company to the Consultant or which are first developed by the
Consultant during the course of performance of Services hereunder and which relate to the Company’s present, past or prospective activities, services and products, all of which shall remain the sole and exclusive property of the Company. The
Consultant shall have no publication rights and all of the same shall belong exclusively to the Company. 

 3.3 Confidential Information. That secret or proprietary information of whatever
kind or nature disclosed to the Consultant (whether or not invented, discovered or developed by the Consultant) or first developed by the Consultant in the course of performance of Services hereunder. Such secret or proprietary information shall
include (unless such information is generally available to the public or known in the industry through no action of the Consultant) information relating to the design, manufacture, application, know-how, research and development relating to the
Company’s products, materials, operating and other cost data, price lists and data relating to pricing of the Company’s products. Such secret or proprietary information shall specifically include, without limitation, all secret or
proprietary information contained in the Company’s manuals, memoranda, plans, drawings and designs, specifications, supply sources, customer lists and records legended or otherwise identified by the Company or the Board of Directors (the
“Board”) as Confidential Information. 
 3.4 Non-Confidential Information. The Consultant’s obligations
under this Section 3 do not apply to any confidential and proprietary material which (a) is or becomes publicly known under circumstances involving no breach by the Consultant of the terms; and/or (b) is generally disclosed to third
parties; and/or (c) was generally known by the Consultant prior to receipt of confidential or proprietary material by the Consultant; and/or (d) was or is approved for release by written authorization of an authorized representative of the
Company. 
 3.5 Non-Disclosure to Third Parties. Except as required by the Consultant’s duties, the Consultant
shall not, at any time, directly or indirectly, use, publish, disseminate or otherwise disclose any Confidential Information, Concepts or Ideas relating to the present, past or prospective business of the Company to any third party without the prior
written consent of the Company, which consent may be denied in each instance and all of the same, together with publication rights, shall belong exclusively to the Company; provided, however, that if the Consultant is required by law (by oral
questions, interrogatories, requests for information or documents, subpoena, civil investigative demand, legal process or similar process), or receives notice that action may be taken to require the Consultant, under law, to disclose any
Confidential Information, it is agreed that, to the extent not legally prohibited, the Consultant will provide to the Company prompt notice of such request so that it may seek an appropriate protective order and/or waive compliance with the
provisions of this Agreement. The Consultant may disclose without liability hereunder only that portion of the Confidential Information that the Consultant is advised by counsel is legally required to be disclosed; provided, that to the
extent not legally prohibited, the Consultant shall give the Company written notice of the information to be disclosed as far in advance of the Consultant’s disclosure as is practicable and, upon the Company’s written request, use
commercially reasonable efforts to assist the Company in its efforts to obtain assurances that confidential treatment will be accorded to such information. 
 3.6 Documents, etc. All documents, procedural manuals, guides, specifications, plans, drawings, designs and similar materials, lists of present, past or prospective customers, customer proposals, invitations to
submit proposals, price lists and data relating to the pricing of the Company’s products and services, records, notebooks and similar repositories of or containing Confidential Information (including all copies thereof) that come into the
Consultant’s possession or control by reason of the Consultant’s relationship, whether prepared by the Consultant or others: (a) are the property of the Company, (b) will not be used by the Consultant in any way adverse to the
Company, (c) will not be removed from the Company’s premises (except as the Consultant’s duties require) and (d) at the termination (for whatever reason), of the Consultant’s relationship with the Company, will be left with,
or forthwith returned by the Consultant to, the Company. 
 3.7 Patents, etc. Any interest in patents, patent
applications, inventions, technological innovations, copyrights, copyrightable works, developments, discoveries, designs, processes, formulas, know-how, data and analysis, whether patentable or not (“Inventions”), which the Consultant, as
a result of rendering consulting Services to the Company under this Agreement, may conceive or develop shall belong exclusively to the Company. 
 4. EQUITABLE RELIEF. The Consultant agrees that any breach of Section 3 above by him would cause irreparable damage to the Company and that, in the event of such breach, the Company shall have, in addition to any and all
remedies of law, the right to an injunction, specific performance or other equitable relief to prevent the violation or threatened violation of the Consultant’s obligations hereunder. In addition, the Company agrees to indemnify the Consultant
and hold him harmless in the event of any legal action resulting from his work performance on behalf of the Company, unless such action results from his own gross negligence or willful misconduct. 
 5. WAIVER. Any waiver by the Company of a breach of any provision of this Agreement shall not operate or be construed as a waiver of any subsequent
breach of the same or any other provision hereof. All waivers by the Company shall be in writing. 

 6. SEVERABILITY; REFORMATION. In case any one or more of the provisions or parts of a provision
contained in this Agreement shall, for any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provision or part of a provision of this Agreement; and
this Agreement shall, to the fullest extent lawful, be reformed and construed as if such invalid or illegal or unenforceable provision, or part of a provision, had never been contained herein, and such provision or part reformed so that it would be
valid, legal and enforceable to the maximum extent possible. Without limiting the generality of the foregoing, if any provision (or part of any provision) contained in this Agreement shall for any reason be held to be excessively broad as to
duration, activity or subject, it shall be construed by limiting and reducing it, so as to be enforceable to the fullest extent compatible with then existing applicable law. 
 7. ASSIGNMENT. The Company shall have the right to assign its rights and obligations under this Agreement to a party which assumes the
Company’s obligations hereunder and in such event, the Company shall give notice to the Consultant of such intention and the Assignment will only be effective if the Consultant assents to the Assignment. If the Consultant does not assent to the
Assignment, he will so notify the Company (in accordance with Article 10), and thereafter this Agreement shall be null and void and without further force or effect. The Consultant shall not have the right to assign his duties or obligations under
this Agreement without the prior written consent of the Company. This Agreement shall be binding upon and inure to the benefit of the Consultant’s heirs and legal representatives in the event of his death or disability. 
 8. HEADINGS. Headings and sub-headings are for convenience only and shall not be deemed to be a part of this Agreement. 
 9. AMENDMENTS. This Agreement may be amended or modified, in whole or in part, only by an instrument in writing signed by all parties hereto.

 10. NOTICES. Any notices or other communications required hereunder shall be in writing and shall be deemed given when delivered in
person, sent by facsimile or by email, or when mailed, by certified or registered first-class mail, postage prepaid, return receipt requested, addressed, if to the Company, at 70 Walnut Street, Wellesley Hills, MA 02481, Facsimile: 781-239-8005,
Attn: Chief Restructuring Officer, or to the Consultant at the address appearing below his signature or such other address of which a party shall have notified the other in accordance with the provisions of this Section 10. 
 11. COUNTERPARTS. This Agreement may be executed in two or more counterparts, each of which shall constitute an original and all of which shall be
deemed a single agreement. 
 12. GOVERNING LAW. This Agreement shall be construed in accordance with and governed for all purposes by
the laws (other than the conflicts of laws rules) of The Commonwealth of Massachusetts. 
 13. SURVIVAL. The provisions of this
Agreement shall survive the termination of the Consultant’s relationship with the Company in accordance with their terms. 
 14. OTHER
AGREEMENTS. This Agreement supersedes all prior understandings and agreements between the Consultant and the Company, whether oral or written, with respect to the subject matter hereof. 
 EXECUTED as an instrument under seal as of the date first above written. 
  

			
	POINT THERAPEUTICS, INC.
		
	By:	 	 /s/ Michael P. Duffy

		 	Michael P. Duffy
		 	Chief Restructuring Officer/Secretary
	
	CONSULTANT
		
	By:	 	 /s/ Richard N. Small

		 	Richard N. Small
		 	 Address: 27 Oriole Road
   Medfield, MA 02052

 Exhibit A 
 Time Sheet 
 Consultant: Richard N. Small 
  

					
	Date	  	 Description
	  	 # of Hours

		  		  	
		  		  	
		  		  	

  

	
	Please submit Time Sheet to:
	
	Michael P. Duffy
	Chief Restructuring Officer
	Point Therapeutics, Inc.
	70 Walnut Street
	 Wellesley Hills, MA 02481
 mduffy@pther.comNon-Employee Director Compensation Plan

 Exhibit 10.2 
 KNOLL, INC. 
 NON-EMPLOYEE DIRECTOR 
 COMPENSATION PLAN 
 1. Purpose. This Non-Employee Director Compensation Plan (the
“Plan”) is intended to promote the interests of Knoll, Inc. (the “Company”) by providing an inducement in the form of fees to certain qualified persons who are not employees of the Company (“Non-Employee Directors”) to
serve as members of the Company’s Board of Directors (the “Board”). In addition, the Plan also seeks to align the interests of these Non-Employee Directors with the interests of the Company’s stockholders by allowing all or a
portion of these fees to be paid in shares of common stock of the Company, par value $0.01 per share (the “Common Stock”), and providing for an annual grant of Common Stock subject to certain restrictions (“Restricted Shares”).

 2. Effective Date. The Plan shall be effective as of October 1, 2007 (the “Effective Date”). 
 3. Administration. The Plan shall be administered by the Board. The Board shall, subject to the provisions of the Plan, have the power to construe the Plan, to
determine all questions hereunder, and to adopt and amend such rules and regulations for the administration of the Plan as it may deem desirable. All decisions, determinations and interpretations of the Board shall be final and binding. 

4. Eligibility. Only Non-Employee Directors are eligible to participate in the Plan. 
 5. Fees Payable to Non-Employee Directors. The following provisions shall govern the payment to Non-Employee Directors of (i) annual fees, (including fees payable to the Audit Committee Chairman)
(“Annual Fees”), (ii) Board meeting fees (“Meeting Fees”) and (iii) reimbursement of reasonable out-of-pocket expenses incurred by the Non-Employee Directors in connection with the performance of their duties as
directors (“Expenses”). 
 (a) Annual Fees. Each person who is a Non-Employee Director shall be entitled to receive without
further action by the Board an Annual Fee equal to $50,000 per calendar year (an “Annual Retainer”), as provided below. In addition, the chairman of the Audit Committee of the Board (the “Audit Committee Chairman”) shall be
entitled to receive a supplemental Annual Fee equal to $10,000 per calendar year served in such capacity (the “Audit Chairman Fee”), as provided below. The Annual Retainer shall be paid in equal installments of $12,500 in arrears on the
last business day of each calendar quarter (each a “Quarterly Payment Date”). In addition, the Audit Chairman Fee shall be paid in equal installments of $2,500 in arrears on each Quarterly Payment Date. 
 (i) Payment of Annual Fees for Partial Quarters. In the event a Non-Employee Director serves on the Board for less than the entire
quarter, the quarterly portion of the Annual Retainer payable for such quarter shall be prorated based on the number of days in such quarter for which such Non-Employee Director served on the Board. In the event a Non- Employee 

 
Director serves as the Audit Committee Chairman for less than the entire quarter, the quarterly portion of the Audit Chairman Fee payable for such quarter
shall be prorated based on the number of days in such quarter for which such Non-Employee Director served as the Audit Committee Chairman. 
 (b) Meeting Fees. Each person who is a Non-Employee Director shall also be entitled to receive $2,500 for each meeting of the Board attended, including each telephonic Board meeting attended. Meeting Fees shall be payable in arrears
on the Quarterly Payment Date immediately following the Board meetings attended. 
 (c) Expense Reimbursements. Each person who is a
Non-Employee Director shall also be entitled to receive reimbursement of Expenses. Expense reimbursements shall be payable in arrears on each Quarterly Payment Date for the Expenses incurred prior to such date. Reimbursement for Expenses shall be
subject to each Non-Employee Director’s submission of a request for reimbursement and all appropriate receipts and/or other documentation required by the Board at least five business days prior to the Quarterly Payment Date for which payment is
sought. Unless otherwise determined by the Board, reimbursement requests submitted late with respect to any Quarterly Payment Date shall be payable on the next Quarterly Payment Date. 
 (d) Method of Payment. Except as elected pursuant to Section 5(e) below, Annual Fees and Meeting Fees shall be payable in cash. Reimbursement
of Expenses shall be payable in cash. 
 (e) Election to Receive Shares of Common Stock in Lieu of Cash. Non-Employee Directors may
elect to receive shares of Common Stock in lieu of all or a portion of the cash payments for Annual Fees and Meeting Fees (a “Stock Election”). Any such election must be made by delivery of a Stock Election Form, a form of which is
attached hereto as Exhibit A, to the Company (attn: Chief Financial Officer) during a window period under the Company’s Insider Trading Policy and prior to the applicable Quarterly Payment Date with respect to which the election is to take
effect. The number of shares of Common Stock issuable pursuant to a Stock Election shall be equal to the value of the cash elected to be foregone in lieu of Common Stock divided by the Fair Market Value (as defined below) of the Common Stock on each
respective Quarterly Payment Date. Shares of Common Stock issued in lieu of Annual Fees and Meeting Fees shall be fully vested and unrestricted shares of Common Stock issued pursuant to the Knoll, Inc. 2007 Stock Incentive Plan (the “Stock
Incentive Plan”); provided, however, that the Board may in its sole discretion choose to issue shares from another stockholder-approved equity plan maintained by the Company. For purposes of the Plan, “Fair Market Value”
means, as of any date when the Common Stock is listed on one or more national securities exchanges, the closing price of one share reported on the principal national securities exchange on which such Common Stock is listed and traded on the date of
determination. If the Common Stock is not listed on an exchange, or representative quotes are not otherwise available, the Fair Market Value shall mean the amount determined by the Board in good faith to be the fair market value per share of Common
Stock. 
  

 2 

 6. Grant of Restricted Stock. 
 (a) Annual Grant. Each calendar year, on the third trading day after the Company publicly announces its annual financial results for the prior year, each Non-Employee Director shall automatically be granted,
without any further action by the Board, a number of Restricted Shares equal to $50,000 divided by the Fair Market Value of one share of the Common Stock on the date of such grant, rounded to the nearest full share (the “Annual Director Stock
Grant”). The Restricted Shares shall be granted pursuant to the Stock Incentive Plan, unless the Board in its sole discretion chooses to issue shares from another stockholder-approved equity plan maintained by the Company and, except as
specifically set forth herein, shall be subject to and governed by the terms of the Stock Incentive Plan (or such other equity plan); provided, however, that any determinations with respect to such Restricted Shares shall be made by the Board.
Except as provided in the Restricted Share Agreement evidencing each Annual Director Stock Grant, the Restricted Shares subject to each Annual Director Stock Grant shall become unrestricted and vest at the rate of 33.3% of the shares granted
(rounded down to the nearest full share) on the first anniversary of the date of grant, an additional 33.3% of the shares granted (rounded down to the nearest full share) on the second anniversary of the date of grant, and the remaining shares
granted on the third anniversary of the date of grant; provided, however, that vesting of the Restricted Shares shall occur only to the extent that the Non-Employee Director recipient remains a member of the Board on the respective vesting date.
Each Annual Director Stock Grant shall be made pursuant to, and shall be subject to such other terms and conditions as set forth in, a Restricted Share Agreement, a form of which is attached hereto as Exhibit B. 
 7. Prohibition of Transfer and Assignment. The right of a Non-Employee Director to the payment of all or a portion of the fees payable or to receive the Common
Stock or Restricted Shares granted under this Plan may not be assigned, transferred, pledged or encumbered, other than by will or the laws of descent and distribution and any attempted assignment or transfer shall be null and void. 
 8. Governing Law. The Plan shall be construed and interpreted in accordance with the internal laws of the State of Delaware, without reference to the principles
of conflicts of law thereof. 
 9. Termination and Amendment of Plan. The Board may at any time terminate the Plan or make such modification or
amendment thereof as it deems advisable. 
  

 3 

 EXHIBIT A 
 KNOLL, INC. 
 NON-EMPLOYEE DIRECTOR COMPENSATION PLAN 
 STOCK ELECTION FORM 
 Pursuant to the
terms of the Knoll, Inc. Non-Employee Director Compensation Plan (the “Plan”), I hereby elect to receive shares of Common Stock in lieu of the Annual Fees and/or Meeting Fees as follows. Capitalized terms shall have the meaning set forth
in the Plan. 
 Stock Election in Lieu of Annual Fees 
 I hereby elect to forego $             on a quarterly basis or             % of the Annual Fees due to me
on each Quarterly Payment Date and instead receive shares of Common Stock rounded to the nearest full share having an equivalent value. 
 Stock
Election in Lieu of Meeting Fees 
 I hereby elect to forego             % of the
Meeting Fees due to me on each Quarterly Payment Date and instead receive shares of Common Stock rounded to the nearest full share having an equivalent value. 
 I UNDERSTAND THAT THIS ELECTION SHALL REMAIN IN EFFECT FOR EACH QUARTERLY PAYMENT DATE UNTIL A SUBSEQUENT ELECTION IS FILED WITH THE COMPANY NULLIFYING OR MODIFYING THIS ELECTION. 
 I UNDERSTAND THAT THE SHARES OF COMMON STOCK ISSUED TO ME IN LIEU OF CASH FOR MY ANNUAL FEES AND/OR MEETING FEES WILL BE UNRESTRICTED FOR U.S. FEDERAL TAX PURPOSES
AND AS SUCH WILL CONSTITUTE INCOME TO ME IN THE YEAR OF GRANT. 
  

	
	
	  
	Non-Employee Director

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}]]